Literature DB >> 19460850

Orexin-stimulated MAP kinase cascades are activated through multiple G-protein signalling pathways in human H295R adrenocortical cells: diverse roles for orexins A and B.

Manjunath Ramanjaneya1, Alex C Conner, Jing Chen, Prashanth Kumar, James E P Brown, Olaf Jöhren, Hendrik Lehnert, Peter R Stanfield, Harpal S Randeva.   

Abstract

Orexins A and B (ORA and ORB) are neuropeptide hormones found throughout the central nervous system and periphery. They are required for a host of physiological processes including mitogen-activated protein kinase (MAPK) regulation, steroidogenesis, appetite control and energy regulation. While some signalling mechanisms have been proposed for individual recombinant orexin receptors in generic mammalian cell types, it is clear that the peripheral effects of orexin are spatially and temporally complex. This study dissects the different G-protein signalling and MAPK pathways activated in a pluripotent human adrenal H295R cell line capable of all the physiological steps involved in steroidogenesis. Both extracellular receptor kinase 1/2 (ERK1/2) and p38 were phosphorylated rapidly with a subsequent decline, in a time- and dose-dependent manner, in response to both ORA and ORB. Conversely, there was little or no direct activation of the ERK5 or JNK pathway. Analysis using signalling and MAPK inhibitors as well as receptor-specific antagonists determined the precise mediators of the orexin response in these cells. Both ERK1/2 and p38 activation were predominantly G(q)- and to a lesser extent G(s)-mediated; p38 activation even had a small G(i)-component. Effects were broadly comparable for both orexin sub-types ORA and ORB and although most of the effects were transmitted through the orexin receptor-1 subtype, we did observe a role for orexin receptor-2-mediated activation of both ERK1/2 and p38. Cortisol secretion also differed in response to ORA and ORB. These data suggest multiple roles for orexin-mediated MAPK activation in an adrenal cell-line, this complexity may help to explain the diverse biological actions of orexins with wide-ranging consequences for our understanding of the mechanisms initiated by these steroidogenic molecules.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19460850     DOI: 10.1677/JOE-08-0536

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  27 in total

1.  The effect of orexin B on steroidogenic acute regulatory protein, P450 side-chain cleavage enzyme, and 3β-hydroxysteroid dehydrogenase gene expression, and progesterone and androstenedione secretion by the porcine uterus during early pregnancy and the estrous cycle.

Authors:  Katarzyna Kisielewska; Edyta Rytelewska; Marlena Gudelska; Marta Kiezun; Kamil Dobrzyn; Karol Szeszko; Kinga Bors; Joanna Wyrebek; Tadeusz Kaminski; Nina Smolinska
Journal:  J Anim Sci       Date:  2019-02-01       Impact factor: 3.159

2.  Orexin/hypocretin receptor signalling: a functional perspective.

Authors:  C S Leonard; J P Kukkonen
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

3.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

4.  OX1 orexin/hypocretin receptor activation of phospholipase D.

Authors:  M H Jäntti; J Putula; P Somerharju; M A Frohman; J P Kukkonen
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

Review 5.  Orexin/hypocretin receptor signalling cascades.

Authors:  J P Kukkonen; C S Leonard
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

6.  Orexin A-mediated stimulation of 3β-HSD expression and testosterone production through MAPK signaling pathways in primary rat Leydig cells.

Authors:  D Zheng; Y Zhao; Y Shen; X Chang; S Ju; L Guo
Journal:  J Endocrinol Invest       Date:  2014-03       Impact factor: 4.256

7.  Orexin A decreases lipid peroxidation and apoptosis in a novel hypothalamic cell model.

Authors:  Tammy A Butterick; Joshua P Nixon; Charles J Billington; Catherine M Kotz
Journal:  Neurosci Lett       Date:  2012-07-11       Impact factor: 3.046

8.  Pharmacological and chemogenetic orexin/hypocretin intervention ameliorates Hipp-dependent memory impairment in the A53T mice model of Parkinson's disease.

Authors:  Milos Stanojlovic; Jean Pierre Pallais; Michael K Lee; Catherine M Kotz
Journal:  Mol Brain       Date:  2019-10-30       Impact factor: 4.041

Review 9.  The dynamic regulation of appetitive behavior through lateral hypothalamic orexin and melanin concentrating hormone expressing cells.

Authors:  Jenna Lee; Lauren Raycraft; Alexander W Johnson
Journal:  Physiol Behav       Date:  2020-10-29

10.  The second intracellular loop of the human cannabinoid CB2 receptor governs G protein coupling in coordination with the carboxyl terminal domain.

Authors:  Congxia Zheng; Linjie Chen; Xiaopan Chen; Xiaobai He; Jingwen Yang; Ying Shi; Naiming Zhou
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.